COPD chronic obstructive pulmonary disease
- related: Pulmonology, Asthma reactive airway disease
- tag: #note
Diagnosis
- diagnosis of COPD must have airflow obstruction
- COPD questionnaires include mMRC, CAT, and SGRQ
- BORG score is used by pulmonary rehab for symptom assessment
- COPD assessment now has category A, B, E
Pathophysiology
Outpatient Treatment
- COPD overview treatment flowchart
- COPD patients should get pneumonia vaccine
- dual LABA LAMA improves FEV1, symptoms, and exacerbation frequency compared to monotherapy
- ICS use increases pneumonia incidence in COPD patients
- ICS are more helpful for COPD patients with higher blood eosinophil count but increased risk of infection
- Triple inhaler improves mortality in COPD patients and should be used over ICS-LABA
- PDE4 inhibitor improves lung function and decreases exacerbations in COPD patients
- oxygen therapy improves survival in patients with resting hypoxemia?
- hypertonic saline does not have any therapeutic benefit in COPD
- pulmonary rehabilitation is beneficial for chronic lung diseases
Severe COPD
- roflumilast benefits both prior and current smoker where as azithromycin only benefits prior
- azithromycin improves immunity and reduces inflammation
- use azithromycin with caution in patients with nonTB mycobacterium infections
- lung volume reduction surgery criteria includes apical emphysema, severe obstruction, single organ disease
- endobronchial valve placement offers nonsurgical option for COPD patients
- dupixent dupilumab for severe COPD on triple therapy improves lung function, quality of life, exacerbations
Inpatient Treatment
Previous Notes
- COPD pathophysiology
- COPD severity assessment
- COPD treatment
- acute COPD exacerbation
- palliative care and COPD
- lung volume reduction surgery LVRS
- selection criteria for lung transplantation in COPD patients
Literature Notes
- COPD clinical trials
- Single breath nitrogen test as predictor of lung function decline and COPD over an 8-year follow-up
- COPD 2023 GOLD Report
Links to this note
- Pulmonology
- COPD 2023 GOLD Report
- diagnosis of COPD must have airflow obstruction
- ICS use increases pneumonia incidence in COPD patients
- azithromycin improves immunity and reduces inflammation
- hypertonic saline does not have any therapeutic benefit in COPD
- dual LABA LAMA improves FEV1, symptoms, and exacerbation frequency compared to monotherapy
- Triple inhaler improves mortality in COPD patients and should be used over ICS-LABA
- Use of fixed ratio can cause over diagnosis of COPD in elderly and under diagnosis in young people
- acute COPD exacerbation
- COPD assessment now has category A, B, E
- COPD clinical trials
- COPD overview treatment flowchart
- COPD pathophysiology
- COPD patients should get pneumonia vaccine
- COPD questionnaires include mMRC, CAT, and SGRQ
- COPD severity assessment
- COPD treatment
- dupixent dupilumab for severe COPD on triple therapy improves lung function, quality of life, exacerbations
- endobronchial valve placement offers nonsurgical option for COPD patients
- ICS are more helpful for COPD patients with higher blood eosinophil count but increased risk of infection
- lung volume reduction surgery criteria includes apical emphysema, severe obstruction, single organ disease
- lung volume reduction surgery LVRS
- palliative care and COPD
- pulmonary rehabilitation is beneficial for chronic lung diseases
- roflumilast benefits both prior and current smoker where as azithromycin only benefits prior
- selection criteria for lung transplantation in COPD patients
- Single breath nitrogen test as predictor of lung function decline and COPD over an 8-year follow-up
- start antibiotics for severe COPD exacerbation